RadNet (+7.7%): Record Earnings and AI Acquisition Fuel Surge
RadNet, a national provider of outpatient diagnostic imaging services, saw its stock surge on high volume after a dual catalyst. The company reported a significant Q4 2025 earnings and revenue beat and simultaneously announced the strategic acquisition of AI firm Gleamer for ~$270M. This news, combined with exceptionally strong 2026 guidance, appears to have driven the aggressive move. But can the costly acquisition deliver on its promised synergies?
The Fundamental Reason
RadNet’s 7.7% move on March 2, 2026, was driven by a trio of positive announcements. The company reported record Q4 2025 revenue of $547.7M and adjusted EPS of $0.23, significantly beating consensus. Simultaneously, RadNet acquired AI firm Gleamer for up to ~$270M, aiming to lead in radiology AI. Management also issued aggressive 2026 guidance for both core imaging and Digital Health segments.
- Q4 Revenue of $547.7M (+14.8% YoY), beating consensus by over 6%.
- Acquired AI firm Gleamer for up to ~$270M, creating the largest global radiology AI solutions provider.
- Guided 2026 Digital Health Annual Recurring Revenue (ARR) to approach or exceed $140M, up from $75.4M.
But here is the interesting part. You are reading about this 7.7% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. High Quality Portfolio is based on an architecture that includes such signals.
The Holistic Price Action Picture
Price structure tells a nuanced story beneath today’s headline move.
The current regime is classified as Uptrend Cooling: Price above both 50D and 200D moving averages and 50D is above 200D — structural bull stack intact. However, the 50D slope is softening slightly. Trend is intact but momentum is decelerating. Watch for slope to stabilize or accelerate; any break below 50D on volume would be a concern.
At $75.22, the stock is 67.2% above its 52-week low of $45.0 and 12.4% below its 52-week high of $85.84.
- Trend Regime: Uptrend Cooling The 50D SMA slope stands at -4.9%, meaning the primary trend anchor is declining.
- Momentum Pulse: Mixed: Momentum signals conflicting across timeframes. The 5D return is 9.7% and 20D return is 7.3%, compared to the 63D return of -9.1% and 126D return of 4.8%.
- Key Levels to Watch: Nearest resistance sits at $83.86 (11.5% away, 6 prior touches). Nearest support is at $71.15 (5.4% below current price, 3 prior touches). The current risk/reward ratio is 2.13x – more upside to resistance than downside to support from here.
- Volatility Context: Normal: 20D realized volatility is 58.0% annualized vs the 1-year norm of 44.2% (compression ratio: 1.31x). The daily expected move is ~4.4% of price – meaning volatility is within its normal historical range.
Understanding price structure, money flow, and price behavior can give you an edge. See more.
What Next?
The immediate technical test for RDNT is the $83.86 zone, a prior resistance level. Sustained buying at or above this zone would signal sustained momentum, but a single day’s price action doesn’t confirm a long-term trend.
To determine if this volatility is structurally justified, it is critical to evaluate the whole picture. You can weigh this recent price action against the company’s growth, multiples, margins, and core thesis at the RDNT Investment Highlights
A 7.7% single-day swing is a stark reminder of the volatility inherent in individual stock picking. While catching a surge is ideal, absorbing a similar drop is the reality of concentrated positions . For investors focused on steady compounding rather than timing specific catalysts, a balanced strategy naturally dampens this kind of single-stock whiplash. If you prefer a more systemic approach to risk management, portfolios are the structured way to handle these market cycles.
Portfolios Over Individual Stock Picks
Individual stocks can soar or tank but one thing matters: staying invested. The right portfolio can help you stay invested, capture upside and mitigate the downside associated with any individual stock.
The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? HQ Portfolio has posted more than 105% in cumulative return since inception, with less risk versus the benchmark index, as evident in HQ Portfolio performance metrics.